Stay updated on IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page.

Latest updates to the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 has been added. The previous notices about government funding and Revision: v3.4.1 have been removed.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center operations with links for updates. The page revision was updated to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check28 days agoChange DetectedMinor UI text changes and label updates on the study page, including Show glossary, capitalization adjustments for 'Last Update Submitted that Met QC Criteria', and footer notes such as No FEAR Act Data and Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4, with no changes to the study details, eligibility criteria, or trial data. This appears to be a technical update to the site interface. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter now shows Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page's revision label updated from v3.2.0 to v3.3.2, a minor version change with no impact on study content, eligibility, or function. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page.